SESN2 and cardiomyopathy: Most of these oxidative, proapoptotic, and fibrotic effects in sesn2 knockdown H9c2 cells and mouse heart tissue were prevented by treatment with an AMPK activator, suggesting that sesn2 blocked LPS-mediated molecular events related to cardiomyopathy via an AMPK-dependent manner.